Citadel Advisors’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,186
Closed -$2.02K 15024
2023
Q1
$2.02K Buy
+25,186
New +$2.97K ﹤0.01% 14220
2022
Q4
Sell
-16,525
Closed -$12K 15312
2022
Q3
$12K Sell
16,525
-2,686
-14% -$1.93K ﹤0.01% 12231
2022
Q2
$8K Buy
19,211
+768
+4% +$907 ﹤0.01% 12631
2022
Q1
$30K Buy
18,443
+1,375
+8% +$1.34K ﹤0.01% 13105
2021
Q4
$18K Buy
17,068
+6,508
+62% +$7.88K ﹤0.01% 13599
2021
Q3
$9K Hold
10,560
﹤0.01% 13689
2021
Q2
$15K Buy
+10,560
New +$10.8K ﹤0.01% 13550

Other funds holding PIIIW

Citadel Advisors's PIIIW Position: Q2 2023 in Review

Citadel Advisors sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 25,186 shares — an estimated $2.02K sold.

Citadel Advisors first reported a position in PIIIW in Q2 2021 and held it in 7 quarters. The position peaked at $30K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

  • Citadel Advisors reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 25,186 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $2.02K.
  • Citadel Advisors first reported a position in P3 Health Partners Inc Warrant in Q2 2021 and held it in 7 quarters.
  • Citadel Advisors's P3 Health Partners Inc Warrant position peaked at $30K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.